What is the recommended treatment for chlamydia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Chlamydia

For uncomplicated chlamydial infections, doxycycline 100 mg orally twice daily for 7 days is the preferred first-line treatment due to its higher efficacy rate of approximately 98% compared to azithromycin's 97%. 1, 2

First-Line Treatment Options

  • Doxycycline 100 mg orally twice daily for 7 days (approximately 98% efficacy) is the preferred first-line treatment for uncomplicated chlamydial infections 1, 2
  • Azithromycin 1 g orally in a single dose (approximately 97% efficacy) is an alternative first-line option, particularly useful when compliance with multi-day regimens is questionable 1, 2
  • Medications should be dispensed on-site when possible, with the first dose directly observed to maximize compliance 1

Alternative Treatment Options

  • Erythromycin base 500 mg orally four times a day for 7 days 1, 3
  • Erythromycin ethylsuccinate 800 mg orally four times a day for 7 days 1
  • Ofloxacin 300 mg orally twice a day for 7 days 1, 2
  • Levofloxacin 500 mg orally once daily for 7 days 1, 2

Special Populations

Pregnancy

  • Azithromycin 1 g orally in a single dose is the preferred treatment during pregnancy 2, 4
  • Amoxicillin 500 mg orally three times a day for 7 days is an alternative option during pregnancy 1, 2
  • Doxycycline is contraindicated during pregnancy 2, 4

Children

  • For children ≥8 years who weigh >45 kg: same as adult dosing 2, 5
  • For children ≥8 years who weigh <45 kg: 2 mg/lb of body weight divided into two doses on the first day, followed by 1 mg/lb of body weight given as a single daily dose or divided into two doses on subsequent days 2, 5

Implementation Considerations

  • Patients should abstain from sexual intercourse for 7 days after single-dose therapy or until completion of a 7-day regimen 1, 2
  • Patients should abstain from sexual intercourse until all sex partners are treated 1
  • All sex partners from the previous 60 days should be evaluated, tested, and treated 1, 2
  • If the last sexual contact was >60 days before diagnosis, the most recent partner should still be treated 1

Follow-Up Recommendations

  • Test-of-cure is not recommended for patients treated with the recommended regimens unless therapeutic compliance is questionable, symptoms persist, or reinfection is suspected 1, 2
  • Consider retesting women approximately 3 months after treatment due to high risk of reinfection 1, 2

Clinical Considerations

  • Treatment failure is uncommon with recommended regimens, with failure rates of 0-3% for males and 0-8% for females 1
  • Patient compliance and cost considerations should be taken into account when selecting a treatment, with azithromycin preferred when compliance is a concern and doxycycline generally less expensive 1
  • For patients with combined chlamydia and bacterial vaginosis, doxycycline 100 mg orally twice daily for 7 days plus metronidazole 500 mg orally twice daily for 7 days is recommended 4

Treatment Efficacy Considerations

  • While both azithromycin and doxycycline are highly effective for urogenital chlamydia, recent evidence suggests doxycycline may be more effective for rectal chlamydia infections 6
  • Gastrointestinal side effects with erythromycin often lead to poor compliance, making it a less desirable alternative 1
  • Single-dose azithromycin therapy allows for directly observed treatment, which can be beneficial in populations where adherence is a concern 7, 8

References

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Combined Chlamydia and Bacterial Vaginosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.